Monocyte-derived alveolar macrophages drive lung fibrosis and persist in the lung over the life span
Open accessThe DOI matches its Crossref record; 87 of the 87 references it cites were found in a registry or an index.
Abstract
Little is known about the relative importance of monocyte and tissue-resident macrophages in the development of lung fibrosis. We show that specific genetic deletion of monocyte-derived alveolar macrophages after their recruitment to the lung ameliorated lung fibrosis, whereas tissue-resident alveolar macrophages did not contribute to fibrosis. Using transcriptomic profiling of flow-sorted cells, we found that monocyte to alveolar macrophage differentiation unfolds continuously over the course of fibrosis and its resolution. During the fibrotic phase, monocyte-derived alveolar macrophages differ significantly from tissue-resident alveolar macrophages in their expression of profibrotic genes. A population of monocyte-derived alveolar macrophages persisted in the lung for one year after the resolution of fibrosis, where they became increasingly similar to tissue-resident alveolar macrophages. Human homologues of profibrotic genes expressed by mouse monocyte-derived alveolar macrophages during fibrosis were up-regulated in human alveolar macrophages from fibrotic compared with normal lungs. Our findings suggest that selectively targeting alveolar macrophage differentiation within the lung may ameliorate fibrosis without the adverse consequences associated with global monocyte or tissue-resident alveolar macrophage depletion.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Recent studies suggest that the latter effect is at least in part due to the contribution of pro-fibrotic macrophages to the activation of fibroblasts into to myofibroblasts in a process that depends on physical contact (14, 15).”
From Modeling mechanical activation of macrophages during pulmonary fibrogenesis for targeted anti-fibrosis therapy (2024) · cites this paper as [14]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Following tissue injury, many resident macrophages die, and the lung parenchyma initiates an innate immune response characterized by the differentiation of bone marrow-derived monocytes to supplement the macrophage pool 61.”
From Nicotinamide phosphoribosyltransferase prompts bleomycin-induced pulmonary fibrosis by driving macrophage M2 polarization in mice (2024) · cites this paper as [61]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The pathogenic role of Mo-AMs in lung fibrosis has been largely attributed to their activity in producing a number of pro-fibrotic mediators, such as TGF-β, PDGF-α, osteopontin (OPN), and MMPs1,3,11,13,15,18,28.”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [1]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“depletion of Mo-AMs via several strategies conferred protection from lung fibrosis in multiple mouse models1,3,10,11,13,20”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [1]
The cited source says what the claim attributes to it.
In the citing paper
“Mo-AMs, but not TR-AMs, are responsible for the pro-fibrotic activity of this group of cells1,3,10,13”
From TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity (2025) · cites this paper as [1]
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Robinson, M. D., McCarthy, D. J., & Smyth, G. K. (2010) · Bioinformatics · doi:10.1093/bioinformatics/btp616 · Cited by 41,364 · cited 2×
“, 2013), and differential gene expression was assessed using edgeR (Robinson et al., 2010; McCarthy et al., 2012) R/Bioconductor packages.”
MethodMacrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337
McCarthy, D. J., Chen, Y., & Smyth, G. K. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks042 · Cited by 5,195 · cited 2×
“, 2013), and differential gene expression was assessed using edgeR (Robinson et al., 2010; McCarthy et al., 2012) R/Bioconductor packages.”
MethodThe M1 and M2 paradigm of macrophage activation: Time for reassessment
Martinez, F. O., & Gordon, S. (2014) · F1000Prime Reports · doi:10.12703/p6-13 · Cited by 4,689 · cited 1×
“Macrophage polarization refers to distinct sets of inflammatory (M1) or fibrotic (M2) genes that are expressed by macrophages in cell culture that are first induced toward differentiation and then treated with LPS and IFN-γ or IL-4, respectively (Martinez and Gordon, 2014; Murray et al., 2014).”
BackgroundMacrophages in Tissue Repair, Regeneration, and Fibrosis
Wynn, T. A., & Vannella, K. M. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.015 · Cited by 4,481
Software for Computing and Annotating Genomic Ranges
Lawrence, M., Huber, W., Pagès, H., Aboyoun, P., Carlson, M., Gentleman, R., Morgan, M. T., & Carey, V. J. (2013) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1003118 · Cited by 4,398 · cited 3×
“…using FastQC, reads were trimmed and aligned to mm10 reference genome using TopHat2, read counts were associated with genes using the GenomicRanges (Lawrence et al., 2013), and differential gene expression was assessed using edgeR (Robinson et al., 2010; McCarthy et al., 2012) R/Bioconductor…”
MethodInfluentialGOrilla: a tool for discovery and visualization of enriched GO terms in ranked gene lists
Eden, E., Navon, R., Steinfeld, I., Lipson, D., & Yakhini, Z. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-48 · Cited by 3,356
Fate Mapping Reveals Origins and Dynamics of Monocytes and Tissue Macrophages under Homeostasis
Yona, S., Kim, K.-W., Wolf, Y., Mildner, A., Varol, D., Breker, M., Strauss-Ayali, D., Viukov, S., Guilliams, M., Misharin, A., et al. (2013) · Immunity · doi:10.1016/j.immuni.2012.12.001 · Cited by 3,245 · cited 2×
“2387 IntroductIon Van Furth and colleagues suggested an adult monocytic origin of all macrophages, but it is now clear that many tissue-resident macrophages, including alveolar macrophages in the lung, are self-renewing populations that arise from fetal progenitors and require minimal input from circuiting adult monoc…”
BackgroundSelf-citationHashimoto, D., Chow, A., Noizat, C., Teo, P., Beasley, M. B., Leboeuf, M., Becker, C. D., See, P., Price, J., Lucas, D., et al. (2013) · Immunity · doi:10.1016/j.immuni.2013.04.004 · Cited by 2,311 · cited 3×
“Extending the findings from several groups (Guilliams et al., 2013; Hashimoto et al., 2013; van de Laar et al., 2016), we found that TR-AMs were remarkably stable, constituting >95% of alveolar macrophages at 14 mo of age (Fig.”
BackgroundTranscriptome-Based Network Analysis Reveals a Spectrum Model of Human Macrophage Activation
Xue, J., Schmidt, S. V., Sander, J., Draffehn, A., Krebs, W., Quester, I., De Nardo, D., Gohel, T. D., Emde, M., Schmidleithner, L., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.01.006 · Cited by 2,210 · cited 1×
“This “macrophage polarization” model is based on limited evidence and is conceptually incomplete (Xue et al., 2014; Nahrendorf and Swirski, 2016).”
Background
Cited by
Items 101–200 of 998
Macrophages and Cardiovascular Health
Frodermann, V., & Nahrendorf, M. (2018) · Physiological Reviews · doi:10.1152/physrev.00068.2017 · Cited by 137
Zhang, X., Li, X., Jia, H., An, G., & Ni, J. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.101058 · Cited by 133
Liu, S., Liu, C., Lv, X., Cui, B., Yan, J., Li, Y., Li, K., Hua, F., Zhang, X., Yu, J., et al. (2021) · Immunity · doi:10.1016/j.immuni.2021.06.008 · Cited by 137
Infection drives meningeal engraftment by inflammatory monocytes that impairs CNS immunity
Rua, R., Lee, J. Y., Silva, A. B., Swafford, I. S., Maric, D., Johnson, K. R., & McGavern, D. B. (2019) · Nature Immunology · doi:10.1038/s41590-019-0344-y · Cited by 123
“However, acute inflammation promotes recruitment of monocyte-derived macrophages that can either phenocopy the resident macrophage pool or dramatically change the immune properties of the tissue 49–51 .”
Advances in the management of idiopathic pulmonary fibrosis and progressive pulmonary fibrosis
Liu, G. Y., Budinger, G. R. S., & Dematte, J. E. (2022) · BMJ · doi:10.1136/bmj-2021-066354 · Cited by 144
“62 75-77 These alveolar macrophages form reciprocal circuits with matrix fibroblasts in which fibroblasts secrete macrophage colony stimulating factor (M-CSF) to maintain alveolar macrophages at the site of injury and alveolar macrophages secrete platelet derived growth factor (PDGF) and other…”
BackgroundSelf-citationAn SFTPC BRICHOS mutant links epithelial ER stress and spontaneous lung fibrosis
Katzen, J. B., Wagner, B. D., Venosa, A., Kopp, M. C., Tomer, Y., Russo, S. J., Headen, A. C., Basil, M. C., Stark, J. M., Mulugeta, S., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.126125 · Cited by 137
“CD11b+Ly6Chi monocytes have been experimentally shown to participate in the development of fibrotic lung disease in exogenous models of injury/repair such as bleomycin and were found to be an early immune population recruited in the SftpcI73T model (10, 39, 67).”
BackgroundResultAyaub, E. A., Dubey, A., Imani, J., Botelho, F. M., Kolb, M. R. J., Richards, C. D., & Ask, K. (2017) · Scientific Reports · doi:10.1038/s41598-017-13511-z · Cited by 131
Aging is associated with a systemic length-associated transcriptome imbalance
Stoeger, T., Grant, R. A., McQuattie‐Pimentel, A. C., Anekalla, K. R., Liu, S. S., Navarro, H. T., Singer, B. D., Abdala‐Valencia, H., Schwake, M., Tétreault, M., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00317-6 · Cited by 138
Self-citationImmune Mechanisms of Pulmonary Fibrosis with Bleomycin
Ishida, Y., Kuninaka, Y., Mukaida, N., & Kondo, T. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043149 · Cited by 136
Chemokine Receptor 2–targeted Molecular Imaging in Pulmonary Fibrosis. A Clinical Trial
Brody, S. L., Gunsten, S. P., Luehmann, H. P., Sultan, D. H., Hoelscher, M., Heo, G. S., Pan, J., Koenitzer, J. R., Lee, E. C., Huang, T., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202004-1132oc · Cited by 125
Immune mechanisms in fibrotic interstitial lung disease
Kamiya, M., Carter, H. M., Espíndola, M. S., Doyle, T. J., Lee, J. S., Merriam, L. T., Zhang, F., Kawano-Dourado, L. B., Sparks, J. A., Hogaboam, C. M., et al. (2024) · Cell · doi:10.1016/j.cell.2024.05.015 · Cited by 140
Fra-2–expressing macrophages promote lung fibrosis
Ucero, A. C., Bakiri, L., Roediger, B., Suzuki, M., Jiménez, M., Mandal, P., Braghetta, P., Bonaldo, P., Paz-Ares, L. G., Torre, C. F., et al. (2019) · Journal of Clinical Investigation · doi:10.1172/jci125366 · Cited by 131
“Monocyte-derived macrophages are key drivers of lung fibrosis, replenishing alveolar macrophages immediately lost upon injury (35, 36, 67).”
BackgroundAlysandratos, K., Russo, S. J., Petcherski, A., Taddeo, E. P., Acín‐Pérez, R., Villacorta-Martín, C., Jean, J., Mulugeta, S., Rodríguez, L. R., Blum, B. C., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109636 · Cited by 125
Ogawa, T., Shichino, S., Ueha, S., & Matsushima, K. (2021) · International Immunology · doi:10.1093/intimm/dxab040 · Cited by 122
Mechanosensing regulates tissue repair program in macrophages
Meizlish, M. L., Kimura, Y., Pope, S. D., Matta, R., Kim, C., Philip, N. H., Meyaard, L., Gonzalez, A., & Medzhitov, R. (2024) · Science Advances · doi:10.1126/sciadv.adk6906 · Cited by 114
“After tissue injury, monocytes produced in the bone marrow enter the tissue from the blood ( 10 , 11 ), where they encounter the growth factor colony-stimulating factor 1 (CSF1), which is produced by stromal cells such as fibroblasts and which induces monocyte differentiation into macrophages ( 12…”
Targeting CSF-1R represents an effective strategy in modulating inflammatory diseases
Xiang, C., Li, H., & Tang, W. (2022) · Pharmacological Research · doi:10.1016/j.phrs.2022.106566 · Cited by 118
Pulmonary fibrosis: pathogenesis and therapeutic strategies
Wang, J., Li, K., Hao, D., Li, X., Zhu, Y., Yu, H., & Chen, H. (2024) · MedComm · doi:10.1002/mco2.744 · Cited by 149
“101,102 Single-cell transcriptomics have identified distinct macrophage populations in fibrotic lungs, including those expressing high levels of SPP1 and CHI3L1.”
BackgroundAllden, S. J., Ogger, P. P., Ghai, P., McErlean, P., Hewitt, R., Toshner, R., Walker, S. A., Saunders, P., Kingston, S., Molyneaux, P. L., et al. (2019) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201809-1775oc · Cited by 111
“Misharin and colleagues recently showed that monocyte-derived rather than fetally derived tissue-resident AMs were essential for the development of pulmonary fibrosis in murine models, whereas deletion of tissue-resident AMs had no effect on the disease (39).”
BackgroundInfluentialDevelopment and Functions of Alveolar Macrophages
Woo, Y. D., Jeong, D., & Chung, D. H. (2021) · Molecules and Cells · doi:10.14348/molcells.2021.0058 · Cited by 110
“Based on these findings, it is also feasible that circulating monocytes might be one of AM precursors under inflammatory conditions (Machiels et al., 2017; Misharin et al., 2017).”
BackgroundEnomoto, Y., Katsura, H., Fujimura, T., Ogata, A., Baba, S., Yamaoka, A., Kihara, M., Abe, T., Nishimura, O., Kadota, M., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40617-y · Cited by 131
Chakraborty, S., Singh, A., Wang, L. X., Wang, X., Sanborn, M. A., Ye, Z., Maienschein‐Cline, M., Mukhopadhyay, A., Ganesh, B. B., Malik, A. B., et al. (2023) · The Journal of Experimental Medicine · doi:10.1084/jem.20221388 · Cited by 111
Nanoparticle targeting of de novo profibrotic macrophages mitigates lung fibrosis
Singh, A., Chakraborty, S., Wong, S. W., Hefner, N. A., Stuart, A., Qadir, A. S., Mukhopadhyay, A., Bachmaier, K., Shin, J.-W., Rehman, J., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2121098119 · Cited by 107
“Mo-Macs in response to inflammatory cues also migrated into the lung airspace and transitioned into de novo AMs, referred to as Mo-AMs (12, 17).”
BackgroundInfluentialUnderstanding the Biology of Self-Renewing Macrophages
Röszer, T. (2018) · Cells · doi:10.3390/cells7080103 · Cited by 92
“Bone marrow-derived monocytes also settle in the lung with aging [5] and in disease [49] and can be long-lived [49].”
The expanding world of tissue‐resident macrophages
Jenkins, S. J., & Allen, J. E. (2021) · European Journal of Immunology · doi:10.1002/eji.202048881 · Cited by 107
Fibrosis: cross-organ biology and pathways to development of innovative drugs
Rieder, F., Nagy, L. E., Maher, T. M., Distler, J. H. W., Kramann, R., Hinz, B., & Prunotto, M. (2025) · Nature Reviews Drug Discovery · doi:10.1038/s41573-025-01158-9 · Cited by 150
Yao, M., Zhang, W., Ma, W., Liu, Q., Xing, L., & Zhao, G.-F. (2019) · Experimental & Molecular Medicine · doi:10.1038/s12276-019-0255-x · Cited by 109
Reactive oxygen species as signaling molecules in the development of lung fibrosis
Gonzalez-Gonzalez, F. J., Chandel, N. S., Jain, M., & Budinger, G. R. S. (2017) · Translational Research · doi:10.1016/j.trsl.2017.09.005 · Cited by 105
“replacement of tissue-resident alveolar macrophages with monocyte-derived cells over the lifespan may adversely affect alveolar epithelial homeostasis in response to injury (67) A better understanding of the molecular events that affect ROS signaling during aging might identify pathways that can be targeted for therap…”
BackgroundSelf-citationMacrophage-derived IL-1β/NF-κB signaling mediates parenteral nutrition-associated cholestasis
Kasmi, K. C. E., Vue, P. M., Anderson, A. L., Devereaux, M. W., Ghosh, S., Balasubramaniyan, N., Fillon, S., Dahrenmoeller, C., Allawzi, A. M., Woods, C., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03764-1 · Cited by 108
Puranik, A. S., Leaf, I. A., Jensen, M. A., Hedayat, A. F., Saad, A., Kim, K.-W., Saadalla, A. M., Woollard, J. R., Kashyap, S., Textor, S. C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-31887-4 · Cited by 104
Teaching Old Dogs New Tricks? The Plasticity of Lung Alveolar Macrophage Subsets
Kulikauskaite, J., & Wack, A. (2020) · Trends in Immunology · doi:10.1016/j.it.2020.08.008 · Cited by 119
“that BM-derived AMs provide protection against murine house dust mite (HDM)-induced asthma [11] or can be a driving force for lung fibrosis following mouse lung injury [12,30,31].”
BackgroundInfluentialZhang, W., Ohno, S., Steer, B., Klee, S., Staab-Weijnitz, C. A., Wagner, D. E., Lehmann, M., Stoeger, T., Königshoff, M., & Adler, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01216 · Cited by 110
“Since lung fibrosis is also driven by monocyte-derived macrophages (29), we hypothesized that macrophage-derived S100a4 might also contribute to the development of lung fibrosis.”
Subramanian, S., Busch, C. J.-L., Molawi, K., Geirsdottir, L., Maurizio, J., Vargas Aguilar, S., Belahbib, H., Gimenez, G., Yuda, R. A. A., Burkon, M., et al. (2022) · Nature Immunology · doi:10.1038/s41590-022-01146-w · Cited by 103
Zhang, S., Shrestha, C. L., & Kopp, B. T. (2018) · Scientific Reports · doi:10.1038/s41598-018-35151-7 · Cited by 105
Human lung tissue resident memory T cells in health and disease
Snyder, M. E., & Färber, D. L. (2019) · Current Opinion in Immunology · doi:10.1016/j.coi.2019.05.011 · Cited by 107
Xie, N., Cui, H., Ge, J., Banerjee, S., Guo, S., Dubey, S., Abraham, E. H., Liu, R.-M., & Liu, G. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00235.2017 · Cited by 105
TRIM33 prevents pulmonary fibrosis by impairing TGF-β1 signalling
Boutanquoi, P., Burgy, O., Beltramo, G., Bellaye, P., Dondaine, L., Marcion, G., Pommerolle, L., Vadel, A., Spanjaard, M., Demidov, O. N., et al. (2020) · European Respiratory Journal · doi:10.1183/13993003.01346-2019 · Cited by 116
Tran, K. A., Pernet, E., Sadeghi, M., Downey, J., Chronopoulos, J., Lapshina, E., Tsai, O., Kaufmann, E., Ding, J., & Divangahi, M. (2024) · Nature Immunology · doi:10.1038/s41590-023-01739-z · Cited by 121
“Although severe pulmonary viral infection often leads to a transient loss of AMs, the kinetics and maintenance of AM repopulation via their self-renewal capacity or/and bone marrow monocytes is a critical determinant of infection outcomes 52,54,55 .”
Spleen-derived classical monocytes mediate lung ischemia-reperfusion injury through IL-1β
Hsiao, H.-M., Fernandez, R., Tanaka, S., Li, W., Spahn, J. H., Chiu, S. F., Akbarpour, M., Ruiz-Perez, D., Wu, Q., Turam, C., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci98436 · Cited by 101
“Myeloid cell populations were identified from fresh specimens using multicolor flow cytometry with our previously described protocols (21, 26, 27).”
Self-citationHyaluronan and Its Interactions With Immune Cells in the Healthy and Inflamed Lung
Johnson, P., Arif, A. A., Lee‐Sayer, S. S. M., & Dong, Y. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02787 · Cited by 105
“HA further promotes their differentiation and maintenance (85, 88, 89).”
BackgroundInfluentialIs the Macrophage Phenotype Determinant for Fibrosis Development?
Lis-López, L., Bauset, C., Seco-Cervera, M., & Cosín‐Roger, J. (2021) · Biomedicines · doi:10.3390/biomedicines9121747 · Cited by 112
Single-Cell Profiling Reveals Immune Aberrations in Progressive Idiopathic Pulmonary Fibrosis
Unterman, A., Zhao, A., Neumark, N., Schupp, J. C., Ahangari, F., Cosme, C., Sharma, P., Flint, J., Stein, Y., Ryu, C., et al. (2024) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202306-0979oc · Cited by 110
Mitochondrial metabolism mediated macrophage polarization in chronic lung diseases
Dong, T., Chen, X., Xu, H., Song, Y., Wang, H., Gao, Y., Wang, J., Du, R., Lou, H., & Dong, T. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2022.108208 · Cited by 106
Bain, C. C., Gibson, D. A., Steers, N. J., Boufea, K., Louwe, P. A., Doherty, C., González-Huici, V., Gentek, R., Magalhaes-Pinto, M., Shaw, T., et al. (2020) · Science Immunology · doi:10.1126/sciimmunol.abc4466 · Cited by 97
Watanabe, S., Markov, N. S., Lu, Z., Piseaux Aillon, R., Soberanes, S., Runyan, C. E., Ren, Z., Grant, R. A., Maciel, M., Abdala-Valencia, H., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2101100118 · Cited by 96
“We used differential expression of Siglec F to separate monocyte-derived alveolar macrophages (CD64 + Siglec F low ) from tissue-resident alveolar macrophages (CD64 + Siglec F high ) (22, 38).”
InfluentialSelf-citationWang, Y., Chaffee, T. S., LaRue, R. S., Huggins, D. N., Witschen, P. M., Ibrahim, A. M., Nelson, A., Machado, H. L., & Schwertfeger, K. L. (2020) · eLife · doi:10.7554/elife.57438 · Cited by 112
“Studies were performed to characterize the turnover and self-renewal properties of Lyve-1 macrophages in adult mammary glands using a shielded bone marrow chimera approach (Misharin et al., 2017).”
MethodAn aberrant immune–epithelial progenitor niche drives viral lung sequelae
Narasimhan, H., Cheon, I. S., Qian, W., Hu, S. S., Parimon, T., Li, C., Goplen, N. P., Wu, Y., Wei, X., Son, Y. M., et al. (2024) · Nature · doi:10.1038/s41586-024-07926-8 · Cited by 123
Matrix biomechanics and dynamics in pulmonary fibrosis
Haak, A. J., Tan, Q., & Tschumperlin, D. J. (2018) · Matrix Biology · doi:10.1016/j.matbio.2017.12.004 · Cited by 95
Reprogramming of profibrotic macrophages for treatment of bleomycin‐induced pulmonary fibrosis
Zhang, F., Ayaub, E. A., Wang, B., Puchulu‐Campanella, E., Li, Y., Hettiarachchi, S. U., Lindeman, S. D., Luo, Q., Rout, S., Srinivasarao, M., et al. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012034 · Cited by 103
“This localization of FRb to Mono-AMs is informative, because these subpopulations are thought to be disproportionately responsible for inducing pulmonary fibrosis (Misharin et al, 2017).”
BackgroundInfluentialHelmin, K. A., Morales-Nebreda, L., Acosta, M. A. T., Anekalla, K. R., Chen, S.-Y., Abdala-Valencia, H., Politanska, Y., Cheresh, P., Akbarpour, M., Steinert, E. M., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci137712 · Cited by 91
Self-citationMonocytes and macrophages: emerging mechanisms and novel therapeutic targets in pulmonary fibrosis
Perrot, C. Y., Karampitsakos, Τ., & Herazo‐Maya, J. D. (2023) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00302.2023 · Cited by 103
Profibrotic Activation of Human Macrophages in Systemic Sclerosis
Bhandari, R., Ball, M. S., Martyanov, V., Popovich, D., Schaafsma, E., Han, S., ElTanbouly, M. A., Orzechowski, N. M., Carns, M. A., Arroyo, E., et al. (2020) · Arthritis & Rheumatology · doi:10.1002/art.41243 · Cited by 104
“More recently, genetic deletion of monocytederived macrophages in a mouse model of bleomycininduced lung injury was shown to significantly attenuate fibrosis (11), further implicating these cells as potential regulators of disease pathogenesis.”
BackgroundSelf-citationRUNX2 promotes fibrosis via an alveolar-to-pathological fibroblast transition
Fang, Y., Chung, S. S. W., Xu, L., Xue, C., Liu, X., Jiang, D., Li, R., Korogi, Y., Yuan, K., Saqi, A., et al. (2025) · Nature · doi:10.1038/s41586-024-08542-2 · Cited by 115
Diverse Injury Pathways Induce Alveolar Epithelial Cell CCL2/12, Which Promotes Lung Fibrosis
Yang, J., Agarwal, M., Ling, S., Teitz‐Tennenbaum, S., Zemans, R. L., Osterholzer, J. J., Sisson, T. H., & Kim, K. K. (2020) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2019-0297oc · Cited by 96
“Recently, numerous studies have suggested an important role for monocyte-derived macrophages in fibrosis (12, 16, 40, 52).”
BackgroundFirst blood: the endothelial origins of hematopoietic progenitors
Canu, G., & Ruhrberg, C. (2021) · Angiogenesis · doi:10.1007/s10456-021-09783-9 · Cited by 103
Coordinated chemokine expression defines macrophage subsets across tissues
Li, X., Mara, A. B., Musial, S. C., Rawat, K., King, W. T., Kolling, F. W., Gerebtsov, N., & Jakubzick, C. (2024) · Nature Immunology · doi:10.1038/s41590-024-01826-9 · Cited by 99
Effects of Influenza on Alveolar Macrophage Viability Are Dependent on Mouse Genetic Strain
Califano, D., Furuya, Y., & Metzger, D. W. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701406 · Cited by 90
IL-8 mediates idiopathic pulmonary fibrosis mesenchymal progenitor cell fibrogenicity
Yang, L., Herrera, J., Gilbertsen, A. J., Hong, X., Smith, K. A., Benyumov, A. O., Bitterman, P. B., & Henke, C. A. (2017) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00200.2017 · Cited by 92
“Consistent with this concept, a recent study found that monocytederived alveolar macrophages were recruited to the lung in the aftermath of bleomycin-induced pulmonary injury and were important in driving the development of lung fibrosis (26).”
ResultLung regeneration: a tale of mice and men
Basil, M. C., & Morrisey, E. E. (2019) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2019.11.006 · Cited by 100
“Recent work has begun to uncover the role of monocyte derived macrophages in the development of dysplastic repair[77,78], highlighting these cells as an emerging contributor to the complex picture of immune cell interactions within the alveolus.”
BackgroundTranscriptomic and epigenetic mechanisms underlying myeloid diversity in the lung
Sajti, E., Link, V. M., Ouyang, Z., Spann, N. J., Westin, E. M., Romanoski, C. E., Fonseca, G. J., Prince, L. S., & Glass, C. K. (2020) · Nature Immunology · doi:10.1038/s41590-019-0582-z · Cited by 88
Bowdish, D. M. E. (2018) · CHEST Journal · doi:10.1016/j.chest.2018.09.003 · Cited by 100
Dagher, R., Copenhaver, A. M., Besnard, V., Berlin, A. A., Hamidi, F., Maret, M., Wang, J., Qu, X., Shrestha, Y., Wu, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-18466-w · Cited by 94
Recovering from a pandemic: pulmonary fibrosis after SARS-CoV-2 infection
Mylvaganam, R. J., Bailey, J. I., Sznajder, J. I., & Sala, M. A. (2021) · European Respiratory Review · doi:10.1183/16000617.0194-2021 · Cited by 105
Self-citationEfferocytosis of apoptotic alveolar epithelial cells is sufficient to initiate lung fibrosis
Kim, K. K., Dotson, M. R., Agarwal, M., Yang, J., Bradley, P. B., Subbotina, N., Osterholzer, J. J., & Sisson, T. H. (2018) · Cell Death & Disease · doi:10.1038/s41419-018-1074-z · Cited by 85
Developmental control of macrophage function
Bonnardel, J., & Guilliams, M. (2017) · Current Opinion in Immunology · doi:10.1016/j.coi.2017.12.001 · Cited by 96
Major lung complications of systemic sclerosis
Denton, C. P., Wells, A. U., & Coghlan, G. (2018) · Nature Reviews Rheumatology · doi:10.1038/s41584-018-0062-0 · Cited by 91
Liu, S.-S., Lv, X.-X., Liu, C., Qi, J., Li, Y.-X., Wei, X.-P., Li, K., Hua, F., Cui, B., Zhang, X., et al. (2019) · Immunity · doi:10.1016/j.immuni.2019.06.014 · Cited by 95
Becerra-Díaz, M., Song, M., & Heller, N. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01698 · Cited by 93
“In asthma and other lung diseases, recruited alveolar macrophages derived from blood monocytes can turn into pathogenic cells, worsening the condition (93, 94).”
BackgroundDistinctive features of severe SARS-CoV-2 pneumonia
Budinger, G. R. S., Misharin, A. V., Ridge, K. M., Singer, B. D., & Wunderink, R. G. (2021) · Journal of Clinical Investigation · doi:10.1172/jci149412 · Cited by 90
Self-citationThe role of lung macrophages in acute respiratory distress syndrome
Dang, W., Tao, Y., Xu, X., Zhao, H., Zou, L., & Li, Y. (2022) · Inflammation Research · doi:10.1007/s00011-022-01645-4 · Cited by 93
The Cardiac Microenvironment Instructs Divergent Monocyte Fates and Functions in Myocarditis
Hou, X., Chen, G., Bracamonte-Baran, W., Choi, H. S., Diny, N. L., Sung, J., Hughes, D., Won, T., Wood, M. K., Talor, M. V., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.06.007 · Cited by 83
“Monocytes are versatile immune cells playing a multi-faceted role in a wide range of inflammatory disorders (Arnold et al., 2007; Misharin et al., 2017; Mishra et al., 2012; Nahrendorf et al., 2007; Olingy et al., 2017; Rahman et al., 2017).”
BackgroundMonocyte-derived alveolar macrophage apolipoprotein E participates in pulmonary fibrosis resolution
Cui, H., Jiang, D., Banerjee, S., Xie, N., Kulkarni, T., Liu, R.-M., Duncan, S. R., & Liu, G. (2020) · JCI Insight · doi:10.1172/jci.insight.134539 · Cited by 84
“Similar transcriptional heterogeneity has also been found in AMs from idiopathic pulmonary fibrosis (IPF) patients (14, 16).”
BackgroundLung Fibrosis and Fibrosis in the Lungs: Is It All about Myofibroblasts?
Zapater, E. O., Signes‐Costa, J., Montero, P., & Roger, I. (2022) · Biomedicines · doi:10.3390/biomedicines10061423 · Cited by 93
Origin and Heterogeneity of Tissue Myeloid Cells: A Focus on GMP-Derived Monocytes and Neutrophils
Ng, L. G., Liu, Z., Kwok, I., & Ginhoux, F. (2023) · Annual Review of Immunology · doi:10.1146/annurev-immunol-081022-113627 · Cited by 103
IL-33–mediated IL-13 secretion by ST2+ Tregs controls inflammation after lung injury
Liu, Q., Dwyer, G. K., Zhao, Y., Li, H., Mathews, L. R., Chakka, A. B., Chandran, U. R., Demetris, J. A., Alcorn, J. F., Robinson, K. M., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.123919 · Cited by 122
Shibata, T., Makino, A., Ogata, R., Nakamura, S., Ito, T., Nagata, K., Terauchi, Y., Oishi, T., Fujieda, M., Takahashi, Y., et al. (2020) · Journal of Clinical Investigation · doi:10.1172/jci125505 · Cited by 81
“The alveolar macrophages that exhibited high Siglec-F expression were tissue-resident alveolar macrophages (TR-AMs), whereas those exhibiting low Siglec-F expression were monocyte-derived macrophages (Mo-AMs) (29).”
BackgroundTrachalaki, A., Tsitoura, E., Mastrodimou, S., Invernizzi, R., Vasarmidi, E., Bibaki, E., Tzanakis, Ν., Molyneaux, P. L., Maher, T. M., & Antoniou, K. M. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.661811 · Cited by 85
“Furthermore, different macrophage/monocyte populations exist in the lungs especially following a fibrotic insult (67).”
BackgroundThe Role of Nrf2 in Pulmonary Fibrosis: Molecular Mechanisms and Treatment Approaches
Wang, Y., Wei, J., Deng, H., Zheng, L., Yang, H. Y., & Lv, X. (2022) · Antioxidants · doi:10.3390/antiox11091685 · Cited by 95
Pneumonia recovery reprograms the alveolar macrophage pool
Guillon, A., Arafa, E. I., Barker, K. A., Belkina, A. C., Martin, I. M. C., Shenoy, A. T., Wooten, A. K., Ana, C. L. D., Dai, A., Labadorf, A. T., et al. (2020) · JCI Insight · doi:10.1172/jci.insight.133042 · Cited by 85
“ry response, the autochthonous alveolar macrophages and the monocyte-derived macrophages recruited by that inflammation have very different transcriptomes and behaviors (17, 45).”
BackgroundInfluentialLi, Q., Cheng, Y., Zhang, Z., Bi, Z., Ma, X., Wei, Y., & Wei, X. (2022) · Clinical and Translational Medicine · doi:10.1002/ctm2.1036 · Cited by 77
Hey, J., Paulsen, M., Tóth, R., Weichenhan, D., Butz, S., Schatterny, J., Liebers, R., Lutsik, P., Plass, C., & Mall, M. A. (2021) · Nature Communications · doi:10.1038/s41467-021-26777-9 · Cited by 77
An IL-9–pulmonary macrophage axis defines the allergic lung inflammatory environment
Fu, Y., Wang, J., Zhou, B., Pajulas, A., Gao, H., Ramdas, B., Koh, B., Ulrich, B. J., Yang, S., Kapur, R., et al. (2022) · Science Immunology · doi:10.1126/sciimmunol.abi9768 · Cited by 84
Macrophages play an essential role in trauma-induced sterile inflammation and tissue repair
Peiseler, M., & Kubes, P. (2018) · European Journal of Trauma and Emergency Surgery · doi:10.1007/s00068-018-0956-1 · Cited by 86
Lung Inflammation in STING-Associated Vasculopathy with Onset in Infancy (SAVI)
David, C., & Frémond, M. (2022) · Cells · doi:10.3390/cells11030318 · Cited by 85
“Lung macrophages represent another population of interest, given their role in coordinating immune responses against airway microbes and pulmonary barrier integrity, and their contribution to lung fibrosis [78,79].”
BackgroundHu, Y., Huang, Y., Zong, L., Lin, J., Liu, X., & Ning, S. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02078-0 · Cited by 89
TREM2 promotes lung fibrosis via controlling alveolar macrophage survival and pro-fibrotic activity
Cui, H., Banerjee, S., Xie, N., Hussain, M., Jaiswal, A., Liu, H., Kulkarni, T., Antony, V. B., Liu, R.-M., Colonna, M., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-57024-0 · Cited by 74
Innate Immunity Effector Cells as Inflammatory Drivers of Cardiac Fibrosis
Baci, D., Bosi, A., Parisi, L., Buono, G., Mortara, L., Ambrosio, G., & Bruno, A. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21197165 · Cited by 78
Leach, S. M., Gibbings, S. L., Tewari, A., Atif, S. M., Vestal, B. E., Danhorn, T., Janssen, W. J., Wager, T. D., & Jakubzick, C. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108337 · Cited by 79
“But during inflammation, monocytes can differentiate into inflammatory and resolving macrophages, which display distinct properties from resident macrophages (Mould et al., 2017, Mould et al., 2019, McCubbrey et al., 2018, Misharin et al., 2017).”
BackgroundCOVID-19 and RA share an SPP1 myeloid pathway that drives PD-L1+ neutrophils and CD14+ monocytes
MacDonald, L., Alivernini, S., Tolusso, B., Elmesmari, A., Somma, D., Perniola, S., Paglionico, A., Petricca, L., Bosello, S. L., Carfì, A., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.147413 · Cited by 79
Kurihara, C., Lecuona, E., Wu, Q., Yang, W., Nunez-Santana, F., Akbarpour, M., Liu, X., Ren, Z., Li, W., Querrey, M., et al. (2021) · JCI Insight · doi:10.1172/jci.insight.147282 · Cited by 75
“CCR2+ CM also have the ability to differentiate into profibrotic AM that may drive lung fibrosis (14).”
BackgroundSelf-citationMcCowan, J., Fercoq, F., Kirkwood, P. M., T’Jonck, W., Hegarty, L. M., Mawer, C. M., Cunningham, R., Mirchandani, A. S., Hoy, A. M., Humphries, D. C., et al. (2021) · Science Immunology · doi:10.1126/sciimmunol.abj2132 · Cited by 83
Li, X., Kolling, F., Aridgides, D. S., Mellinger, D., Ashare, A., & Jakubzick, C. (2022) · Life Science Alliance · doi:10.26508/lsa.202201458 · Cited by 83
Öz, H. H., Cheng, E.-C., Pietro, C. D., Tebaldi, T., Biancon, G., Zeiss, C. J., Zhang, P., Huang, P. H., Esquibies, S. S., Britto, C. J., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2022.111797 · Cited by 80
Zhang, Y., Tang, T., Wang, B., Wen, Y., Feng, Y., Yin, Q., Jiang, W., Zhang, Y., Li, Z., Wu, M., et al. (2024) · Advanced Science · doi:10.1002/advs.202309752 · Cited by 72
ISM1 protects lung homeostasis via cell-surface GRP78-mediated alveolar macrophage apoptosis
Lam, T. Y. W., Nguyen, N., Peh, H. Y., Shanmugasundaram, M., Chandna, R., Huat, T. J., Ong, C. B., Hossain, M. Z., Venugopal, S., Zhang, T., et al. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2019161119 · Cited by 77
Revisiting regulatory T cells as modulators of innate immune response and inflammatory diseases
Ou, Q., Power, R., & Griffin, M. D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1287465 · Cited by 81
Ahangari, F., Price, N. L., Malik, S., Chioccioli, M., Bärnthaler, T., Adams, T. S., Kim, J., Pradeep, S. P., Ding, S., Cosmos, C., et al. (2023) · JCI Insight · doi:10.1172/jci.insight.158100 · Cited by 70
NOX4 modulates macrophage phenotype and mitochondrial biogenesis in asbestosis
He, C., Larson‐Casey, J. L., Davis, D., Hanumanthu, V. S., Longhini, A. L. F., Thannickal, V. J., Gu, L., & Carter, A. B. (2019) · JCI Insight · doi:10.1172/jci.insight.126551 · Cited by 72
“Recent data have highlighted a role of monocyte-derived macrophages in the development of pulmonary fibrosis (15).”
BackgroundMethodYu, Y.-R. A., Malakhau, Y., Yu, C.-H. A., Phelan, S.-L. J., Cumming, R. I., Kan, M. J., Mao, L., Rajagopal, S., Piantadosi, C. A., & Gunn, M. D. (2020) · The Journal of Immunology · doi:10.4049/jimmunol.1900239 · Cited by 72
Macrophage TLR4 and PAR2 Signaling: Role in Regulating Vascular Inflammatory Injury and Repair
Rayees, S., Rochford, I., Joshi, J. C., Joshi, B., Banerjee, S., & Mehta, D. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02091 · Cited by 79
“It is recognized that monocytes can also access the alveolar space and differentiate into AM8 over the course of pulmonary disease, such as pulmonary fibrosis (44, 45).”
BackgroundHan, Z., Chen, Q., Zheng, D., Chen, K., Huang, Q., Zhuang, Z., & Zhang, X. (2023) · Advanced Materials · doi:10.1002/adma.202302551 · Cited by 73
Metadata
- Authors
- Misharin, A. V., Morales-Nebreda, L., Reyfman, P. A., Cuda, C. M., Walter, J. M., McQuattie-Pimentel, A. C., Chen, C.-I., Anekalla, K. R., Joshi, N., Williams, K. J. N., Abdala-Valencia, H., Yacoub, T. J., Chi, M., Chiu, S., Gonzalez-Gonzalez, F. J., Gates, K., Lam, A. P., Nicholson, T. T., Homan, P. J., Soberanes, S., Dominguez, S., Morgan, V. K., Saber, R., Shaffer, A., Hinchcliff, M., Marshall, S. A., Bharat, A., Berdnikovs, S., Bhorade, S. M., Bartom, E. T., Morimoto, R. I., Balch, W. E., Sznajder, J. I., Chandel, N. S., Mutlu, G. M., Jain, M., Gottardi, C. J., Singer, B. D., Ridge, K. M., Bagheri, N., Shilatifard, A., Budinger, G. R. S., & Perlman, H.
- Affiliations
- Northwestern University (US)
- Division of Pulmonary and Critical Care Medicine, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 1
- Division of Rheumatology, Department of Medicine, Feinberg School of Medicine, Northwestern University, Chicago, IL 2
- Scripps Research Institute (US)
- University of Chicago (US)
- Corresponding author
- Perlman, Harris
- ORCID
- Misharin, Alexander V.
- Reyfman, Paul A.
- Cuda, Carla M.
- Walter, James M.
- McQuattie-Pimentel, Alexandra C.
- Chen, Ching-I
- Anekalla, Kishore R.
- Joshi, Nikita
- Chiu, Stephen
- Gonzalez-Gonzalez, Francisco J.
- Lam, Anna P.
- Nicholson, Trevor T.
- Homan, Philip J.
- Soberanes, Saul
- Dominguez, Salina
- Morgan, Vince K.
- Saber, Rana
- Shaffer, Alexander
- Hinchcliff, Monique
- Marshall, Stacy A.
- Bharat, Ankit
- Berdnikovs, Sergejs
- Bhorade, Sangeeta M.
- Bartom, Elizabeth T.
- Morimoto, Richard I.
- Balch, William E.
- Sznajder, Jacob I.
- Chandel, Navdeep S.
- Mutlu, Gökhan M.
- Jain, Manu
- Gottardi, Cara J.
- Singer, Benjamin D.
- Ridge, Karen M.
- Bagheri, Neda
- Shilatifard, Ali
- Budinger, G.R. Scott
- Perlman, Harris
- Venue
- Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2017-07-10
- Volume
- 214
- Issue
- 8
- Pages
- 2387-2404
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC5551573
- OpenAlex
- W2736034593
- Cited by
- 1,133
- References
- 87
- Citations by year
- 2026: 139 · 2025: 131 · 2024: 156 · 2023: 135 · 2022: 136 · 2021: 128 · 2020: 134 · 2019: 81 · 2018: 77 · 2017: 15
- FWCI
- 68.89
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- The Journal of Experimental Medicine (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- NIH (AR064313, HL128867, T32 DK077662, HL125940, AG049665, HL048129, HL071643, HL085534, ES015024, ES025644, HL079190, HL124664, ES013995, AR064546, HL134375)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR061593)
- Scleroderma Foundation
- Department of Defense (PR141319)
- BD Bioscience
- Northwestern University (5T32 HL076139-13)
- American Society for Transplant Surgery Foundation
- Thoracic Surgery Foundation
- Society of University Surgeons
- American Association of Thoracic Surgery
- Parker B. Francis
- Veterans Administration (BX000201)
- Mabel Greene Myers
- National Cancer Institute (P30 CA060553)
- Feinberg School of Medicine
- American Thoracic Society
- Topics
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
- Health Sciences › Medicine › Surgery › Transplantation: Methods and Outcomes
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Keywords
- pulmonary fibrosis, alveolar macrophages, monocyte-derived macrophages, tissue-resident macrophages, monocyte-to-macrophage differentiation, fibrosis resolution, gene deletion, gene expression profiling
- MeSH terms
- Animals, Cell Differentiation, Fibrosis, Humans, Lung, Monocytes, Macrophages, Alveolar, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.